Skip to main content
Top
Published in: Journal of Neurology 1/2016

01-01-2016 | Original Communication

Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review

Authors: R. Dersch, H. Sommer, S. Rauer, J. J. Meerpohl

Published in: Journal of Neurology | Issue 1/2016

Login to get access

Abstract

Controversy exists about residual symptoms after pharmacological treatment of Lyme neuroborreliosis. Reports of disabling long-term sequels lead to concerns in patients and health care providers. We systematically reviewed the available evidence from studies reporting treatment of Lyme neuroborreliosis to assess the prevalence and spectrum of residual symptoms after treatment. A literature search was performed in three databases and three clinical trial registers to find eligible studies reporting on residual symptoms in patients after pharmacological treatment of LNB. Diagnosis must have been performed according to consensus-derived case definitions. No restrictions regarding study design or language were set. Symptom prevalence was pooled using a random-effects model. Forty-four eligible clinical trials and studies were found: 8 RCTs, 17 cohort studies, 2 case–control studies, and 17 case series. The follow-up period in the eligible studies ranged from 7 days to 20 years. The weighted mean proportion of residual symptoms was 28 % (95 % CI 23–34 %, n = 34 studies) for the latest reported time point. Prevalence of residual symptoms was statistically significantly higher in studies using the “possible” case definition (p = 0.0048). Cranial neuropathy, pain, paresis, cognitive disturbances, headache, and fatigue were statistically significantly lower in studies using the “probable/definite” case definition. LNB patients may experience residual symptoms after treatment with a prevalence of approximately 28 %. The prevalence and spectrum of residual symptoms differ according to the applied case definition. Symptoms like fatigue are not reported in studies using the “probable/definite” case definition. As the “possible” case definition is more unspecific, patients with other conditions may be included. Reports of debilitating fatigue and cognitive impairment after LNB, a “post-Lyme syndrome”, could therefore be an artifact of unspecific case definitions in single studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA (1999) Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 18:697–703CrossRef Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA (1999) Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 18:697–703CrossRef
2.
go back to reference Halperin JJ (2012) Lyme disease: a multisystem infection that affects the nervous system. Continuum 18:1338–1350PubMed Halperin JJ (2012) Lyme disease: a multisystem infection that affects the nervous system. Continuum 18:1338–1350PubMed
4.
go back to reference Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I, European Federation of Neurological S (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol Off J Eur Fed Neurol Soc 17(8–16):e11–e14 Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I, European Federation of Neurological S (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol Off J Eur Fed Neurol Soc 17(8–16):e11–e14
5.
go back to reference Halperin JJ, Logigian EL, Finkel MF, Pearl RA (1996) Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 46:619–627CrossRef Halperin JJ, Logigian EL, Finkel MF, Pearl RA (1996) Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology. Neurology 46:619–627CrossRef
7.
go back to reference Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G et al (2006) The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am 43:1089–1134CrossRef Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G et al (2006) The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am 43:1089–1134CrossRef
8.
go back to reference Eikeland R, Mygland A, Herlofson K, Ljostad U (2013) Risk factors for a non-favorable outcome after treated European neuroborreliosis. Acta Neurol Scand 127:154–160CrossRefPubMed Eikeland R, Mygland A, Herlofson K, Ljostad U (2013) Risk factors for a non-favorable outcome after treated European neuroborreliosis. Acta Neurol Scand 127:154–160CrossRefPubMed
9.
go back to reference Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A (1994) Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 21:454–461PubMed Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A (1994) Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 21:454–461PubMed
10.
go back to reference Cameron D, Gaito A, Harris N, Bach G, Bellovin S, Bock K, Bock S, Burrascano J, Dickey C, Horowitz R et al (2004) Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther 2:S1–13CrossRefPubMed Cameron D, Gaito A, Harris N, Bach G, Bellovin S, Bock K, Bock S, Burrascano J, Dickey C, Horowitz R et al (2004) Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther 2:S1–13CrossRefPubMed
11.
go back to reference Edelsberg JS, Lord C, Oster G (2011) Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother 45:1483–1490CrossRefPubMed Edelsberg JS, Lord C, Oster G (2011) Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother 45:1483–1490CrossRefPubMed
12.
go back to reference Sili U, Kaya A, Mert A, Group HSVES (2014) Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol Off Publ Pan Am Soc Clin Virol 60:112–118CrossRef Sili U, Kaya A, Mert A, Group HSVES (2014) Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients. J Clin Virol Off Publ Pan Am Soc Clin Virol 60:112–118CrossRef
13.
go back to reference Fowler A, Forsman L, Eriksson M, Wickstrom R (2013) Tick-borne encephalitis carries a high risk of incomplete recovery in children. J Pediatr 163:555–560CrossRefPubMed Fowler A, Forsman L, Eriksson M, Wickstrom R (2013) Tick-borne encephalitis carries a high risk of incomplete recovery in children. J Pediatr 163:555–560CrossRefPubMed
14.
go back to reference Cerar D, Cerar T, Ruzic-Sabljic E, Wormser GP, Strle F (2010) Subjective symptoms after treatment of early Lyme disease. Am J Med 123:79–86CrossRefPubMed Cerar D, Cerar T, Ruzic-Sabljic E, Wormser GP, Strle F (2010) Subjective symptoms after treatment of early Lyme disease. Am J Med 123:79–86CrossRefPubMed
16.
go back to reference Dersch R, Freitag MH, Schmidt S, Sommer H, Rucker G, Rauer S, Meerpohl JJ (2014) Efficacy and safety of pharmacological treatments for neuroborreliosis—protocol for a systematic review. Syst Rev 3:117PubMedCentralCrossRefPubMed Dersch R, Freitag MH, Schmidt S, Sommer H, Rucker G, Rauer S, Meerpohl JJ (2014) Efficacy and safety of pharmacological treatments for neuroborreliosis—protocol for a systematic review. Syst Rev 3:117PubMedCentralCrossRefPubMed
17.
go back to reference Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O’Connell S, Ornstein K, Strle F, Gray J (2011) Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 17:69–79 Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O’Connell S, Ornstein K, Strle F, Gray J (2011) Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 17:69–79
18.
go back to reference Yates F (1934) Contingency table involving small numbers and the χ 2 test. J R Stat Soc 1:217–235 Yates F (1934) Contingency table involving small numbers and the χ 2 test. J R Stat Soc 1:217–235
19.
go back to reference Dunn OJ (1961) Multiple comparisons among Means. J Am Stat Assoc 56:52–64CrossRef Dunn OJ (1961) Multiple comparisons among Means. J Am Stat Assoc 56:52–64CrossRef
22.
go back to reference Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC (2001) Evaluation of study patients with Lyme disease, 10–20-year follow-up. J Infect Dis 183:453–460CrossRefPubMed Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC (2001) Evaluation of study patients with Lyme disease, 10–20-year follow-up. J Infect Dis 183:453–460CrossRefPubMed
23.
go back to reference Eikeland R, Mygland A, Herlofson K, Ljostad U (2011) European neuroborreliosis: quality of life 30 months after treatment. Acta Neurol Scand 124:349–354CrossRefPubMed Eikeland R, Mygland A, Herlofson K, Ljostad U (2011) European neuroborreliosis: quality of life 30 months after treatment. Acta Neurol Scand 124:349–354CrossRefPubMed
24.
go back to reference Benke T, Gasse T, Hittmair-Delazer M, Schmutzhard E (1995) Lyme encephalopathy: long-term neuropsychological deficits years after acute neuroborreliosis. Acta Neurol Scand 91:353–357CrossRefPubMed Benke T, Gasse T, Hittmair-Delazer M, Schmutzhard E (1995) Lyme encephalopathy: long-term neuropsychological deficits years after acute neuroborreliosis. Acta Neurol Scand 91:353–357CrossRefPubMed
Metadata
Title
Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review
Authors
R. Dersch
H. Sommer
S. Rauer
J. J. Meerpohl
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 1/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7923-0

Other articles of this Issue 1/2016

Journal of Neurology 1/2016 Go to the issue